Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,801 public trials 833 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana

NCT04862975

Conditions
Blood-Borne Infections, Breastmilk Fed Infants of Mothers on Select DOI, Communicable Diseases, +13 more
Locations
  • Botswana-UPenn Partnership Botswana, Gaborone, South Africa
  • Lesirane Clinic Botswana, Gaborone, South Africa
  • Mogoditshane Clinic KDC Botswana, Gaborone, South Africa
  • Old Naledi Clinic Botswana, Gaborone, South Africa
View Trial Details
Completed

Burden of Hepatitis D Virus (HDV) Infection in Italy

NCT05723068

Conditions
Chronic Disease, Chronic Hepatitis D, Digestive System Diseases, +12 more
Locations
  • Università degli Studi di Bari Aldo Moro Bari, Italy
  • Gastroenterology Hepatology and Transplantation, ASST Bergamo Bergamo, Italy
  • Malattie Infettive, ASST Bergamo Bergamo, Italy
  • Dipartimento di Scienze Mediche e Chirurgiche, Università degli Studi di Bologna Bologna, Italy
View all 36 locations
View Trial Details
Completed

A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus

NCT03379675

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Core Healthcare Group Cerritos, California, United States
  • eStudySite Chula Vista, California, United States
  • SC Clinical Research Inc Garden Grove, California, United States
  • Lake Internal Medicine Associates Eustis, Florida, United States
View all 124 locations
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

NCT02315703

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Aurora, Colorado, United States
  • Miami, Florida, United States
  • Rockville, Maryland, United States
  • Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Ad26.COV2.S in Adults (COVID-19)

NCT04436276

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Optimal Research San Diego, California, United States
  • Optimal Research Melbourne, Florida, United States
  • Optimal Research Peoria, Illinois, United States
  • Optimal Research Rockville, Maryland, United States
View Trial Details

Related conditions